UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034483
Receipt number R000039046
Scientific Title Verification of the effect of mindfulness meditation training tool for Mild Cognitive Impairment prevention
Date of disclosure of the study information 2018/10/15
Last modified on 2022/08/10 12:05:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effect of mindfulness meditation training tool for Mild Cognitive Impairment prevention

Acronym

Verification of the effect of mindfulness meditation training tool for MCI prevention

Scientific Title

Verification of the effect of mindfulness meditation training tool for Mild Cognitive Impairment prevention

Scientific Title:Acronym

Verification of the effect of mindfulness meditation training tool for MCI prevention

Region

Japan


Condition

Condition

Mild Cognitive Impairment

Classification by specialty

Neurology Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Intervention using a tool to induce a mindfulness state by a meditation method to regulate breathing, we verify effect of emotion conversion and brain function improvement. We focus particularly on whether real time feedback of autonomic nervous conditions results in a significant improvement of autonomic function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

As autonomic nerve evaluation, electrocardiogram CVRR value (Coefficient of Variation of R-R intervals).
We examine the effect difference depending on the presence / absence of the feedback function of the tool, as follows;
(1) Comparison between self-style meditation and meditation induction by tools.
(2) Comparison between self-style meditation before and after the tool intervention period (MCI patient group: 2 weeks, 5 minutes each day in the morning and evening, young healthy group: 4 weeks, 5 minutes once daily).

Key secondary outcomes

TMT (trail making test) as a brain's attention / performance function evaluation.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Behavior,custom Other

Interventions/Control_1

Intervention period: 2 weeks
Intervention amount: 5 minutes each
Frequency: twice daily
Function to feed back the state of the autonomic nerve of the tool that induces the mindfulness state to be used in real time: Yes

Interventions/Control_2

Intervention period: 2 weeks
Intervention amount: 5 minutes each
Frequency: twice daily
Function to feed back the state of the autonomic nerve of the tool that induces the mindfulness state to be used in real time: None

Interventions/Control_3

Intervention period: 4 weeks
Intervention amount: 5 minutes each
Frequency: once a day
Function to feed back the state of the autonomic nerve of the tool that induces the mindfulness state to be used in real time: Yes

Interventions/Control_4

Intervention period: 4 weeks
Intervention amount: 5 minutes each
Frequency: once a day
Function to feed back the state of the autonomic nerve of the tool that induces the mindfulness state to be used in real time: None

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) MCI Patient Group: MCI patient (under 85 years old) visits every week to the day care of our clinic.
(2) Young healthy subject group: Young healthy individuals (30 to 65 years old) who routinely care for dementia patients visiting our clinic.

Key exclusion criteria

(1) Subjects having arrhythmia
(2) Subjects judged as unsuitable for this study by the investigator for other reasons

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Asada

Organization

Memory Clinic Ochanomizu

Division name

Medical care Division

Zip code

113-0034

Address

4F Ochanomizu Igakukaikan, 1-5-34, Yushima, Bunkyo-ku, Tokyo, JAPAN

TEL

03-6801-8718

Email

asada@memory-cl.jp


Public contact

Name of contact person

1st name Mieko
Middle name
Last name Tanaka

Organization

Brain Functions Lab., Inc.

Division name

Research Division

Zip code

230-0046

Address

1-508 Leading Venture Plaza, 75-1, Ono-cho, Tsurumi-ku, Yokohama JAPAN

TEL

050-3774-6162

Homepage URL


Email

mtanaka@bfl.co.jp


Sponsor or person

Institute

Memory Clinic Ochanomizu

Institute

Department

Personal name



Funding Source

Organization

Citizen Watch Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Brain Functions Lab., Inc., Research Ethics Committee

Address

LVP1-508, 75-1, Ono-cho, Tsurumi-ku, Yokohama 230-0046 JAPAN

Tel

050-3774-6162

Email

ethics@bfl.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

メモリークリニックお茶の水


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

42

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 10 Month 07 Day

Date of IRB

2018 Year 10 Month 07 Day

Anticipated trial start date

2018 Year 10 Month 08 Day

Last follow-up date

2019 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 14 Day

Last modified on

2022 Year 08 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039046


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name